Fundraising FoxVenture Capital Investment Management
Venture capitalSan Francisco · Pre-Seed–Series A · 7 people tracked
Also known as HAMBRECHT PARTNERS HOLDINGS, LLC
Find your way into Venture Capital Investment Management
Sign up to see every warm intro you have to Venture Capital Investment Management
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Venture Capital Investment Management team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
WRH invests in early-stage healthcare disruptors, grounding its strategy in Clayton Christensen's Disruption Theory. The firm targets new companies entering lower-cost, lower-performing, or non-mainstream market tiers rather than those competing directly with incumbents, arguing these have better odds of growth and survival. It views healthcare as ripe for disruption as decision-making shifts from hospitals and doctors toward consumers and self-insured corporations, creating opportunities to back young companies at lower valuations. WRH uses a proprietary big-data system, MESE, to screen hundreds of early-stage candidates daily and proactively pursue top targets through outbound sourcing alongside traditional inbound networks.
Source: firm website, verified Oct 27, 2026.
Team · 7 people
from the firm's website
Partner at Hambrecht Ventures, founder of WR Hambrecht+Co and co-founder of Hambrecht & Quist. He has overseen investments in nearly 700 companies, including early backing of firms such as Apple, Amazon, Google and Genentech, and serves on the boards of Buoy Health and PatientsLikeMe.
Managing Partner at Hambrecht Ventures who has worked alongside Bill Hambrecht for a decade. Previously CEO of Salon Media, co-founder of Asiacontent.com, and an emerging-markets equities analyst at Goldman Sachs; she sits on the boards of Tasso, Proov, and Golden.
CFO of WR Hambrecht+Co since 2014 with over 25 years as a senior finance executive. Previously CFO at Wells Fargo Securities and held controller and regulatory roles at Charles Schwab; holds a BS in Accounting & Finance from USC.
Advisor and former Managing Partner at WRH+Co (2013-2018). Previously President and CEO at Wells Fargo Securities, Director of Worldwide Sales at H&Q, and an Executive Director at Morgan Stanley; holds a BA from Yale University.
Advisor and longtime partner in Hambrecht Ventures Funds 1 and 2 focused on early-stage technology and bioscience investments in the US and China. A retired Hewlett Packard corporate vice president, he has served on boards including Omnitura Therapeutics, NeoPhotonics and Lenovo.
Created and manages the technical team behind WRH's proprietary MESE big-data system used to identify, analyze, and monitor disruptive companies.
Partner leading operations and HR, having held various HR and operations roles at WR Hambrecht+Co since 1999 supporting Hambrecht Capital, Hambrecht Ventures and portfolio companies. Previously an AVP at Bank of America.
What they invest in
from 9 of 24 portfolio companiesHealthtech ×5Digital Health ×4AI & Machine Learning ×3Biotech ×3Medical Devices ×2Advanced Manufacturing ×1AgTech ×1Cleantech ×1
HQs:United States×8
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×22 founders×44+ founders×2
Investments · 24 tracked
founders shown can be your intro pathBy year:2019 · 22014 · 13 dated
A Place for Mom is a senior care referral service that helps families find and compare senior living and care options, including assisted living, memory care, independent living, home care, nursing homes, and senior apartments.
ConsumerDigital HealthHealthtechMarketplacesWellness & FitnessVernon Hills, US
Douglas Hirsch(Director)Trevor Bezdek(Co-Chairman & Director)Jonathan Stevens(Executive Officer)Thomas Richards(Executive Officer, Director)Christine Leahy(Executive Officer)Dennis Berger(Executive Officer)
Co-investorsBain Capital Double Impact Fund LPBain Capital Life SciencesBain Capital Tech OpportunitiesBattery VenturesBessemer Venture PartnersBlue Sea Capital+38 more
AeroFarms uses indoor vertical farming, artificial intelligence, and plant biology on a proprietary agriculture platform to grow fresh produce year-round with traceability and food safety.
AgTechAI & Machine LearningFoodTech
David Rosenberg(Founder)in
Co-investorsIngka InvestmentsMiddleland CapitalADM CapitalAllianceBernsteinDoha Venture CapitalGrosvenor Food & AgTech+2 more
Arcimoto builds compact all-electric vehicles, including the FUV (Fun Utility Vehicle) and MUV (Modular Utility Vehicle), designed as right-sized alternatives to conventional cars.
Advanced ManufacturingCleantechHardwareMobility & TransportationEugene, US
MARK DOUGLAS FROHNMAYER(Executive Officer, Director)DOUGLAS MARTIN CAMPOLI(Executive Officer)Mark Frohnmayer(Founder)
BoardTHOMAS THURSTON(Director)JEFFERSON MOORE CURL(Director)TERRY LEON BECKER(Director)
Co-investorsE8 Angels
Calithera Biosciences was a clinical-stage biopharmaceutical company developing small-molecule oncology drugs targeting tumor metabolism, including the glutaminase inhibitor telaglenastat.
BiotechSouth San Francisco, US
Susan M. Molineaux(Executive Officer, Director)inWilliam Waddill(Executive Officer)in
BoardJean M. George(Director)Deepa Pakianathan(Director)inRalph E. Christoffersen(Director)Jonathan Drachman(Director)
Co-investorsLongwood FundThe Column Group
Color operates a nationwide, oncologist-led Virtual Cancer Clinic that delivers cancer screening, early detection, diagnosis, treatment management, and survivorship care at population scale.
AI & Machine LearningBiotechDigital HealthHealthtechBurlingame, US
Othman Laraki(CEO)inElad Gil(Executive Officer, Director)in
BoardTaneja Hemant(Director)
Co-investorsNat Turner8VCGeneral CatalystKhosla Ventures
.png)
Jounce Therapeutics was a Cambridge, MA clinical-stage biopharmaceutical company developing cancer immunotherapies, including antibodies targeting ICOS and LILRB2/ILT4, guided by a biomarker-driven discovery platform.
BiotechCambridge, US
Kim C. Drapkin(Executive Officer)Anna L. Barry(Executive Officer)inRichard Murray(Executive Officer, Director)
BoardRobert Tepper(Director)inCary Pfeffer(Director)inRobert Kamen(Director)in
Co-investorsBoutique Venture PartnersGENERAL INCEPTIONNextech InvestSofinnova VenturesThird Rock VenturesWellington Management
HealthtechNew York, US
Ran Shaul(Founder)Allon Bloch(Founder)inAshok Balakrishnan(Executive Officer)Chen Yehudai(Executive Officer)inYaron Savoray(Executive Officer)Adam Singolda(Founder)
Co-investorsComcast VenturesLerer HippeauMangrove Capital PartnersNat TurnerNotable CapitalPartners Resolute+11 more
Neurotrack provides remote cognitive assessment tools for clinicians to detect early cognitive decline through eye-tracking technology, enabling earlier intervention for patients at risk of Alzheimer's and cognitive conditions.
AI & Machine LearningDigital HealthHealthtechMedical DevicesRedwood City, US
Elli Kaplan(Co-founder & CEO)inDr. Stuart Zola(Scientific Co-Founder)Dr. Elizabeth Buffalo(Scientific Co-Founder)Cecelia Manzanares(Co-founder)Elizabeth Buffalo(Founder)Stuart Zola(Founder)
Co-investorsRethink ImpactSozo Ventures
Uri Raz(Founder)in
Co-investorsAccess Technology VenturesQualcomm VenturesTransLink Capital
Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.
Digital HealthHealthtechMedical DevicesSeattle, US
Ben Casavant(Co-Founder and Chief Executive Officer)inErwin Berthier(Co-Founder and Chief Technology Officer)inAlan Levy(Director)
BoardElizabeth Hambrecht(Director)Paul Conley(Director)in
Co-investorsForesite CapitalJ2 VenturesMerck Global Health Innovation FundMSD Global Health Innovation FundOMX VenturesRA Capital+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AmuseBurt's BeesCardiometrixElevateFintech platform in ChinaMedidataMindstrongMothershipOmbreŌnRoSurveySampling InternationalTeamViewerToms of Maine
Exits · 4
1 IPOs · 3 acquisitions · showing 3A Place for MomNASDAQ: GDRXSurveySampling Internationalacq. by Research Now (merger, later rebranded as Dynata)Toms of Maineacq. by Colgate-Palmolive
Frequently asked questions
- How many investments has Venture Capital Investment Management made?
- Venture Capital Investment Management has 24 tracked investments, 4 of which have exited.
- What stage does Venture Capital Investment Management invest at?
- Venture Capital Investment Management invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Venture Capital Investment Management focus on?
- Venture Capital Investment Management focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices, Sector Agnostic.
- Where is Venture Capital Investment Management located?
- Venture Capital Investment Management is headquartered in San Francisco, US.
- Who does Venture Capital Investment Management co-invest with?
- Venture Capital Investment Management most often shares deals with Nat Turner, Battery Ventures, Bessemer Venture Partners, among 70 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.